A detailed history of Principal Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 1,694 shares of MRNA stock, worth $66,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,694
Previous 1,764 3.97%
Holding current value
$66,777
Previous $118 Million 40.25%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$36.85 - $63.93 $2,579 - $4,475
-70 Reduced 3.97%
1,694 $70.4 Million
Q3 2024

Oct 28, 2024

SELL
$63.64 - $125.14 $14,700 - $28,907
-231 Reduced 11.58%
1,764 $118 Million
Q2 2024

Jul 31, 2024

BUY
$101.21 - $166.61 $48,074 - $79,139
475 Added 31.25%
1,995 $237 Million
Q1 2024

May 10, 2024

SELL
$85.37 - $115.44 $39,867 - $53,910
-467 Reduced 23.5%
1,520 $162 Million
Q4 2023

Feb 07, 2024

BUY
$69.51 - $104.43 $138,116 - $207,502
1,987 New
1,987 $198 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.